Only the assets are what is being purchased. BZNE I believe will continue to trade and be a viable entity after they acquire the assets of that other biotech whose name I can't remember.
So I think they are simply selling warrants to purchase stock in the new entity, and shouldn't affect the asset acquisition IMO.